In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body’s glucose levels and drives the course of the disease, so preserving or restoring beta cell mass is a central treatment goal.
Continue Reading this article here
